Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

It is a weighty problem. One in eight people across the world now have obesity, leaving them at higher risk of Type 2 diabetes, heart disease, arthritis, fatty liver disease, and certain cancers.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Natural diet pills have become dominantly relevant these days since the obesity levels are rising every year. Losing and ...

the company believe their product can provide a 10-20 per cent weight loss with regular use. “A couple of years ago there was an article published in Nature about an exercise pill that was based ...

but it is taken as an oral pill rather than an injection. Who is it for? Rybelsus is approved for adults with type 2 diabetes to improve blood sugar levels when combined with diet and exercise.